Francois Brisebois
Stock Analyst at LifeSci Capital
(3.24)
# 2,393
Out of 4,361 analysts
366
Total ratings
40%
Success rate
2.6%
Average return
Main Sectors:
Stocks Rated by Francois Brisebois
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CMPS COMPASS Pathways | Reiterated: Buy | $23 | $13.33 | +72.54% | 14 | Jun 2, 2026 | |
| PRAX Praxis Precision Medicines | Reiterated: Buy | $795 → $731 | $258.08 | +183.25% | 26 | Jun 2, 2026 | |
| SVRA Savara | Reiterated: Buy | $10 | $5.25 | +90.48% | 30 | May 29, 2026 | |
| DYN Dyne Therapeutics | Reiterated: Buy | $44 | $17.24 | +155.22% | 27 | May 26, 2026 | |
| IRD Opus Genetics | Maintained: Buy | $10 | $3.99 | +150.63% | 8 | May 16, 2026 | |
| LRMR Larimar Therapeutics | Rated: Buy | $25 | $3.30 | +657.58% | 6 | May 16, 2026 | |
| DFTX Definium Therapeutics | Maintained: Buy | $38 | $22.86 | +66.23% | 24 | May 16, 2026 | |
| OVID Ovid Therapeutics | Maintained: Buy | $5 | $2.40 | +108.33% | 14 | May 16, 2026 | |
| AQST Aquestive Therapeutics | Reiterated: Buy | $9 | $3.93 | +129.01% | 16 | May 15, 2026 | |
| MPLT MapLight Therapeutics | Reiterated: Buy | $45 | $27.34 | +64.59% | 1 | May 15, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $95 | $57.33 | +65.71% | 28 | May 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $39.90 | - | 12 | Apr 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $2.39 | - | 27 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $61 | $30.91 | n/a | 15 | Apr 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $65 | $16.77 | n/a | 27 | Apr 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $4 → $80 | $16.10 | n/a | 5 | Mar 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 | $5.69 | n/a | 2 | Mar 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $12 | $1.64 | n/a | 4 | Mar 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 → $30 | $6.64 | n/a | 3 | Feb 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $11 | $5.03 | n/a | 14 | Jan 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $8.34 | n/a | 1 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $4.55 | n/a | 11 | Aug 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $36 | $13.76 | n/a | 7 | Jul 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $5.77 | n/a | 12 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $90 → $20 | $1.26 | n/a | 3 | Aug 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8 → $60 | $2.92 | n/a | 4 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $5 | $2.04 | n/a | 4 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $80 → $100 | $0.00001 | n/a | 2 | Sep 27, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $18 | $0.6412 | n/a | 1 | Jul 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $91.42 | n/a | 1 | May 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $18 | $0.6911 | n/a | 1 | Feb 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $8.5 → $4 | $1.36 | n/a | 2 | Sep 10, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $68 → $72 | $8.21 | n/a | 2 | Sep 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $23 → $15 | $0.0002 | n/a | 2 | Sep 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $2 → $1 | $0.3402 | n/a | 4 | Aug 22, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $1.5 → $1 | $1.15 | n/a | 2 | Jul 29, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $50 | $2.71 | n/a | 1 | Jun 27, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $11 | $1.19 | n/a | 1 | Feb 20, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $26 | $3.17 | n/a | 1 | May 24, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $210 | $0.063 | n/a | 1 | Feb 13, 2018 |
COMPASS Pathways
Jun 2, 2026
Reiterated: Buy
Price Target: $23
Current: $13.33
Upside: +72.54%
Praxis Precision Medicines
Jun 2, 2026
Reiterated: Buy
Price Target: $795 → $731
Current: $258.08
Upside: +183.25%
Savara
May 29, 2026
Reiterated: Buy
Price Target: $10
Current: $5.25
Upside: +90.48%
Dyne Therapeutics
May 26, 2026
Reiterated: Buy
Price Target: $44
Current: $17.24
Upside: +155.22%
Opus Genetics
May 16, 2026
Maintained: Buy
Price Target: $10
Current: $3.99
Upside: +150.63%
Larimar Therapeutics
May 16, 2026
Rated: Buy
Price Target: $25
Current: $3.30
Upside: +657.58%
Definium Therapeutics
May 16, 2026
Maintained: Buy
Price Target: $38
Current: $22.86
Upside: +66.23%
Ovid Therapeutics
May 16, 2026
Maintained: Buy
Price Target: $5
Current: $2.40
Upside: +108.33%
Aquestive Therapeutics
May 15, 2026
Reiterated: Buy
Price Target: $9
Current: $3.93
Upside: +129.01%
MapLight Therapeutics
May 15, 2026
Reiterated: Buy
Price Target: $45
Current: $27.34
Upside: +64.59%
May 9, 2026
Rated: Buy
Price Target: $95
Current: $57.33
Upside: +65.71%
Apr 1, 2026
Downgraded: Hold
Price Target: n/a
Current: $39.90
Upside: -
Oct 24, 2025
Rated: Hold
Price Target: n/a
Current: $2.39
Upside: -
Apr 8, 2025
Reiterated: Buy
Price Target: $61
Current: $30.91
Upside: n/a
Apr 4, 2025
Reiterated: Buy
Price Target: $65
Current: $16.77
Upside: n/a
Mar 28, 2025
Maintained: Buy
Price Target: $4 → $80
Current: $16.10
Upside: n/a
Mar 20, 2025
Reiterated: Buy
Price Target: $16
Current: $5.69
Upside: n/a
Mar 3, 2025
Reiterated: Buy
Price Target: $12
Current: $1.64
Upside: n/a
Feb 28, 2025
Reiterated: Buy
Price Target: $28 → $30
Current: $6.64
Upside: n/a
Jan 8, 2025
Reiterated: Buy
Price Target: $11
Current: $5.03
Upside: n/a
Aug 26, 2024
Rated: Hold
Price Target: n/a
Current: $8.34
Upside: n/a
Aug 26, 2024
Rated: Hold
Price Target: n/a
Current: $4.55
Upside: n/a
Jul 29, 2024
Maintained: Buy
Price Target: $36
Current: $13.76
Upside: n/a
Jul 1, 2024
Reiterated: Buy
Price Target: $6
Current: $5.77
Upside: n/a
Aug 17, 2023
Maintained: Buy
Price Target: $90 → $20
Current: $1.26
Upside: n/a
Apr 3, 2023
Maintained: Buy
Price Target: $8 → $60
Current: $2.92
Upside: n/a
Mar 23, 2023
Maintained: Buy
Price Target: $5
Current: $2.04
Upside: n/a
Sep 27, 2022
Maintained: Buy
Price Target: $80 → $100
Current: $0.00001
Upside: n/a
Jul 18, 2022
Initiated Coverage: Buy
Price Target: $18
Current: $0.6412
Upside: n/a
May 11, 2020
Initiated Coverage: Buy
Price Target: n/a
Current: $91.42
Upside: n/a
Feb 4, 2020
Initiated Coverage: Buy
Price Target: $18
Current: $0.6911
Upside: n/a
Sep 10, 2019
Maintained: Buy
Price Target: $8.5 → $4
Current: $1.36
Upside: n/a
Sep 4, 2019
Maintained: Buy
Price Target: $68 → $72
Current: $8.21
Upside: n/a
Sep 4, 2019
Maintained: Buy
Price Target: $23 → $15
Current: $0.0002
Upside: n/a
Aug 22, 2019
Maintained: Hold
Price Target: $2 → $1
Current: $0.3402
Upside: n/a
Jul 29, 2019
Maintained: Hold
Price Target: $1.5 → $1
Current: $1.15
Upside: n/a
Jun 27, 2019
Upgraded: Buy
Price Target: $50
Current: $2.71
Upside: n/a
Feb 20, 2019
Maintained: Buy
Price Target: $11
Current: $1.19
Upside: n/a
May 24, 2018
Reiterated: Buy
Price Target: $26
Current: $3.17
Upside: n/a
Feb 13, 2018
Maintained: Buy
Price Target: $210
Current: $0.063
Upside: n/a